WCMNY
IMGN

Westchester Capital Management (New York)’s Immunogen Inc IMGN Stock Holding History

Westchester Capital Management (New York)’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,364,927
Closed -$40.5M – 301
2023
Q4 		$40.5M Buy
+1,364,927
New +$27.2M 1.42% 18

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Westchester Capital Management (New York)'s IMGN Position: Q1 2024 in Review

Westchester Capital Management (New York) sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,364,927 shares — an estimated $40.5M sold.

Westchester Capital Management (New York) first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $40.5M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Westchester Capital Management (New York) reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 1,364,927 Immunogen Inc shares in Q1 2024, an estimated $40.5M.
  • Westchester Capital Management (New York) first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Westchester Capital Management (New York)'s Immunogen Inc position peaked at $40.5M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2024, filed 15 May 2024.